Esperion Therapeutics Inc. (ESPR) at a glance

Esperion Therapeutics Inc. (ESPR) is a small-cap Healthcare company. It trades at $3.18, with a -1.8% profit margin and revenue growth of 23.2%. It does not pay a dividend. Vestovix scores it 57/100 overall. Its strongest dimension is Growth (75/100) and its weakest is Value (40/100). Its volatility is roughly in line with the market.

Price

$3.18

Market cap

$811.7M

P/E ratio

n/a

Dividend yield

None

Beta

1.07

52-week range

$1.10 to $4.18